Gianfranco Sinagra
0000-0003-2700-8478
306 papers found
Refreshing results…
Non-transplant surgery for heart failure and severe left ventricular dysfunction. Opportunities and limitations.
Dilated cardiomyopathy: indication and role of endomyocardial biopsy | Cardiomiopatia dilatativa: quando è indicata e cosa chiedere alla biopsia endomiocardica.
Positive inotropes and beta-blockers: Alternative or complementary therapies? | Scompenso cardiaco refrattario. Inotropi positivi e betabloccanti: Trattamenti alternativi o complementari?
Hospital statistics as a tool for epidemiologic studies: Heart failure in Trieste | Le statistiche ospedaliere come strumento di studio epidemiologico: Io scompenso cardiaco a Trieste
Refractory heart failure. Positive inotropes and beta blockers: alternative or complementary treatments? | Scompenso cardiaco refrattario. Inotropi positivi e betabloccanti: trattamenti alternativi o complementari?
Treatment of heart failure: An update | Aggiornamenti in tema di terapia dello scompenso cardiaco
Dobutamine echocardiography in idiopathic dilated cardiomyopathy: Clinical and prognostic implications
Dilated cardiomyopathy: etiology, clinical criteria for diagnosis and screening of the familial form | Cardiomiopatia dilatativa: eziologia, criteri clinici di diagnosi e screening della forma familiare.
Heart failure programs and comprehensive management in heart failure | Modelli integrati tra ospedale e territorio per l'assistenza al paziente con scompenso cardiaco
Etiology, diagnostic criteria and screening of familial dilated cardiomyopathy | Cardiomiopatia dilatativa: Eziologia, criteri clinici di diagnosi e screening della forma familiare
Diagnosis of dilated cardiomyopathy: Which role for endomycardial biopsy? | Cardiomiopatia dilatativa: Quando è indicata e cosa chiedere alla biopsia endomiocardica
The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review
Benefits of beta-blockers in heart failure: a class specific effect?
How medical therapy for heart failure has changed in the light of large clinical trials | Come è cambiata la terapia medica dello scompenso cardiaco alla luce dei grandi trial clinici
Incidence and predictors of sudden cardiac death during long-term follow-up in patients with dilated cardiomyopathy on optimal medical therapy.
Metoprolol-induced functional benefit in dilated cardiomyopathy is sustained over four years and favorably influences outcome.
New Insights Into the Molecular Basis of Familial Dilated Cardiomyopathy.
Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement
Are all beta blocking agents equally effective in the treatment of chronic heart failure?
Clinical relevance of right ventricular dysplasia/cardiomyopathy
Missing publications? Search for publications with a matching author name.